Eris Lifesciences reports marginal fall in Q3 consolidated net profit

18 Jan 2023 Evaluate

Eris Lifesciences has reported results for third quarter ended December 31, 2022.

The company has reported fall of 4.49% in its net profit at Rs 99.38 crore for Q3FY23 as compared to Rs 104.06 crore for the corresponding quarter previous year. However, total income of the company increased by 8.06% to Rs 335.49 crore for the quarter as compared to Rs 310.47 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported fall of 0.53% in its net profit at Rs 100.23 crore for Q3FY23 as compared to Rs 100.77 crore for the same quarter in the previous year. However, total income of the company increased by 26.13% to Rs 425.50 crore for the quarter under review as compared to Rs 337.34 crore for the same quarter in the previous year.

Eris Lifesciences Share Price

1389.70 -22.85 (-1.62%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.